Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05095077Phase 1Completed
Phase 1, randomised, double-blind trial in urinary incontinence (UI) and fecal incontinence (FI) comparing Tadalafil First with Placebo First (2 arms). Primary endpoint: Placebo-corrected change in opening urethral pressure. Started Aug 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05095077.